Clinical Trials Browser

Phase 1/2 × Lymphoma × cemiplimab × Clear all

NCT03769181 2025-09-23

A Study of Isatuximab-based Therapy in Participants With Lymphoma

Phase 1/2 Terminated

58 enrolled 37 charts

Lymphoma